Table 2: Linear regression analysis
showing association of glycaemicvariability (SD) with (log)PAID score in
patients on different therapeutic regimen.
|
Total
group (n = 124) |
Diet
or oral agents only (n = 56) |
Insulin
treatment (n = 68) |
|||
|
Β
(CI) |
P |
Β
(CI) |
P |
Β
(CI) |
P |
|
|
|
|
|
|
|
SD |
0.20 (-0.01-0.42) |
0.067
|
-0.03 (-0.42-0.35) |
0.858
|
0.33
(0.01 - 0.65) |
0.042
|
MV |
0.16 (-0.07-0.38) |
0.167 |
-0.02 (-0.41-0.38) |
0.926 |
0.26 (-0.07 - 0.59) |
0.119 |
MV + HbA1c |
0.00 (-0.26-0.26) |
0.977 |
-0.28 (-0.71-0.15) |
0.201 |
0.17 (-0.21 - 0.54) |
0.371 |
PAID = Problem Areas
in Diabetes Scale
MV = Adjusted for pre-defined covariates (age,
sex, duration of diabetes, use of antidepressant drugs and education level)
MV + HbA1c = Also adjusted for HbA1c